"The Utah Diabetes and Endocrinology Center's goal is to help diabetes patients, by reducing complications and suffering with the end goal of ultimately preventing diabetes."

During the past decade, Utah Diabetes Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Utah Diabetes Center" #1 sponsor was "AstraZeneca" with 3 trials, followed by "Brigham and Women's Hospital" with 1 trials sponsored, "Medtronic Diabetes" with 1 trials sponsored, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials sponsored and "University of Utah" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Utah Diabetes Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "University of Chicago" with 1 trials as a collaborator and "University of Michigan" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Utah Diabetes Center" are "Diabetes Mellitus, Non-Insulin-Dependent" (2 trials), "Cardiovascular Disease" (1 trials), "Delayed Puberty" (1 trials), "Precocious Puberty" (1 trials) and "Type 1 Diabetes" (1 trials). Many other conditions were trialed in "Utah Diabetes Center" in a lesser frequency.

Most popular intervention types in "Utah Diabetes Center" are "Drug" (5 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "AC2993" (2 trials), "Placebo" (2 trials), "AC2993 10.0 mcg" (1 trials), "AC2993 2.5 mcg" (1 trials) and "AC2993 5.0 mcg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Utah Diabetes Center" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Utah Diabetes Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Utah Diabetes Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Utah Diabetes Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".